James Wyche

Affiliations: 
Brown University, Providence, RI 
Area:
Molecular Biology, Cell Biology
Google:
"James Wyche"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dimas K, Hatziantoniou S, Tseleni S, et al. (2007) Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice. Apoptosis : An International Journal On Programmed Cell Death. 12: 685-94
Balan KV, Prince J, Han Z, et al. (2007) Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia Phytomedicine. 14: 263-272
Balan KV, Wang Y, Chen SW, et al. (2006) Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene. Biochemical Pharmacology. 72: 573-81
Balan KV, Sitaras NM, Dimas K, et al. (2006) Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line Chemotherapy. 52: 137-146
Balan KV, Demetzos C, Prince J, et al. (2005) Induction of apoptosis in human colon cancer HCT116 cells treated with an extract of the plant product, Chios mastic gum. In Vivo (Athens, Greece). 19: 93-102
Wang Y, Wang B, Cheng J, et al. (2005) FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochemical Pharmacology. 69: 249-54
Chatterjee D, Goldman M, Braastad CD, et al. (2004) Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta. International Journal of Oncology. 25: 503-9
Chatterjee D, Bai Y, Wang Z, et al. (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. The Journal of Biological Chemistry. 279: 17515-23
Pantazis P, Han Z, Balan K, et al. (2003) Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models. Anticancer Research. 23: 3623-38
Hu X, Balan KV, Ramos-DeSimone N, et al. (2003) Differential susceptibility to 9-nitrocamptothecin (9-NC)-induced apoptosis in clones derived from a human ovarian cancer cell line: possible implications in the treatment of ovarian cancer patients with 9-NC. Anti-Cancer Drugs. 14: 427-36
See more...